The global legal cannabis market is set to explode in the next few years. Contributing to this is the growing adoption of cannabis in several medical fields such as cancer, mental disorders, and chronic pain, as well as the change in focus to recreational use.
With legalization across various parts of the states and countries, comes the need to ensure quality control, standardized testing, quality assurance and compliance to common industry and well-established regulatory standards. As with any other pharmaceutical drug, medicinal cannabis will need to undergo rigorous testing to ensure that it is both fit for human consumption and is delivered at the right potency to provide the medical and recreational outcomes that it is being taken for.
Even as growers, processors, packagers and distributors of cannabis look to big opportunities, they have to know what quality assurance measures will need to be taken. Despite the absence of a cannabis-specific regulation at this time, most will need to go further voluntarily to ensure the production and sale of the safest and most consistent cannabis quality.
Quality in cannabis manufacturing starts at the source – the growers and suppliers. Companies need to ensure that raw materials and active ingredients meet the set standards. This requires internal and periodic supplier audits and documentation to verify the purity of ingredients. Even after this, there has to be internal testing upon receipt of the materials, verifying that the COAs [certificates of analysis] match their claims. Companies need to produce robust SOPs and in-process quality checks in addition to process testing. Each step of the manufacturing process must be controlled through Good Manufacturing Practices (GMP) at the minimum.
